APA (7th ed.) Citation

S, P., J, L., RD, C., JJ, L., GK, S., FS, H., . . . E, K. (2020). Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071. Molecular cancer therapeutics, 19(4), 1031. https://doi.org/10.1158/1535-7163.MCT-19-0098

Chicago Style (17th ed.) Citation

S, Piperno-Neumann, et al. "Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071." Molecular Cancer Therapeutics 19, no. 4 (2020): 1031. https://doi.org/10.1158/1535-7163.MCT-19-0098.

MLA (9th ed.) Citation

S, Piperno-Neumann, et al. "Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071." Molecular Cancer Therapeutics, vol. 19, no. 4, 2020, p. 1031, https://doi.org/10.1158/1535-7163.MCT-19-0098.